chr20-59019556-TG-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 5P and 4B. PVS1_StrongPP5BS2
The NM_030773.4(TUBB1):c.35delG(p.Cys12fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000036 ( 0 hom. )
Consequence
TUBB1
NM_030773.4 frameshift
NM_030773.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.89
Genes affected
TUBB1 (HGNC:16257): (tubulin beta 1 class VI) This gene encodes a member of the beta tubulin protein family. Beta tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. This protein is specifically expressed in platelets and megakaryocytes and may be involved in proplatelet production and platelet release. A mutations in this gene is associated with autosomal dominant macrothrombocytopenia. Two pseudogenes of this gene are found on chromosome Y.[provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.974 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PP5
Variant 20-59019556-TG-T is Pathogenic according to our data. Variant chr20-59019556-TG-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 586966.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=3, Pathogenic=2, Likely_pathogenic=1}.
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB1 | NM_030773.4 | c.35delG | p.Cys12fs | frameshift_variant | 1/4 | ENST00000217133.2 | NP_110400.1 | |
TUBB1 | XM_017028085.2 | c.-10+3012delG | intron_variant | XP_016883574.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBB1 | ENST00000217133.2 | c.35delG | p.Cys12fs | frameshift_variant | 1/4 | 1 | NM_030773.4 | ENSP00000217133.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152216Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
8
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251248Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135822
GnomAD3 exomes
AF:
AC:
8
AN:
251248
Hom.:
AF XY:
AC XY:
5
AN XY:
135822
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461886Hom.: 0 Cov.: 30 AF XY: 0.0000330 AC XY: 24AN XY: 727240
GnomAD4 exome
AF:
AC:
53
AN:
1461886
Hom.:
Cov.:
30
AF XY:
AC XY:
24
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74372
GnomAD4 genome
AF:
AC:
8
AN:
152216
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:6Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Macrothrombocytopenia, isolated, 1, autosomal dominant Pathogenic:4Uncertain:1
Pathogenic, no assertion criteria provided | research | Unidade de Genética Molecular, Centro Hospitalar Universitário do Porto | Jul 07, 2022 | Variant identified in homozygosity in two of five affected members in the same family. PVS1, PP5, PP1 - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 14, 2024 | Variant summary: TUBB1 c.35delG (p.Cys12LeufsX12) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 3.2e-05 in 251248 control chromosomes (gnomAD). c.35delG has been reported in the literature in individuals affected with congenital hypothyroidism or inherited platelet disorders (Stoupa_2018, Bastida_2018). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 34662886, 28983057, 32757236, 30446499). ClinVar contains an entry for this variant (Variation ID: 586966). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | Apr 12, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 12, 2023 | - - |
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 586966). This premature translational stop signal has been observed in individual(s) with thrombocytopenia and/or TUBB1-related macrothrombocytopenia (PMID: 28983057, 30446499, 32757236). This variant is present in population databases (rs773248042, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Cys12Leufs*12) in the TUBB1 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in TUBB1 cause disease. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 14, 2024 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29333906, 30446499, 31589614, 34662886, 34516618, 32757236, 28983057, 37647632) - |
Congenital hypothyroidism Pathogenic:1
Pathogenic, no assertion criteria provided | research | Polak associated Lab, IMAGINE Institute | Oct 18, 2016 | - - |
TUBB1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 06, 2022 | The TUBB1 c.35delG variant is predicted to result in a frameshift and premature protein termination (p.Cys12Leufs*12). This variant has been reported in an individual with thyroid dysgenesis, and the variant was inherited from a parent with mild thyroid asymmetry but with normal thyroid function (Stoupa et al. 2018. PubMed ID: 30446499). This variant has also been reported in an individual with an inherited platelet disorder (Bastida et al. 2018. PubMed ID: 28983057) and an individual with nonsyndromic thrombocytopenia (Guéguen et al. 2020. PubMed ID: 32757236). This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/20-57594611-TG-T). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at